Papers
9
Total Citations
222
H-Index
8
About
Anatoly Dritschilo is a prominent radiation oncologist whose research has significantly advanced the treatment of localized prostate cancer, with particular expertise in stereotactic body radiation therapy (SBRT) and robotic radiotherapy systems. His work has helped establish SBRT as a precise, effective alternative to conventional radiation approaches, addressing critical questions around treatment planning optimization, toxicity management, and patient-reported outcomes. Among his most influential contributions is his development of overlap-volume histogram-driven planning methodology for robotic SBRT, which improved plan quality for organ-confined prostate cancer and has garnered nearly 60 citations. His investigations into PSA kinetics, urinary morbidity, proctitis, and dysuria following SBRT have provided clinicians with essential data to refine treatment protocols and improve patient quality of life. Notably, his early histopathologic analysis of prostatic tissue following hypofractionated robotic radiation therapy offered the first direct tissue-level evidence of this technique's biological effects. Beyond radiation technology, Dritschilo has also contributed to cancer genetics, co-authoring research identifying frequent ATM missense mutations in breast cancer patients, reflecting the breadth of his oncologic interests. His cumulative body of work, spanning molecular biology to clinical outcomes, underscores his lasting influence on modern radiation oncology practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2ATM missense mutations are frequent inpatients with breast cancer55 citations · 2003
- 3
- 4
- 5
- 6
- 7
- 8
- 9